Maurice R Hilleman

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi request reprint Overview of the needs and realities for developing new and improved vaccines in the 21st century
    Maurice R Hilleman
    Merck Institute for Vaccinology, Merck and Co, Inc, West Point, PA 19486, USA
    Intervirology 45:199-211. 2002
  2. pmc Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections
    Maurice R Hilleman
    Merck Institute for Vaccinology, West Point, PA 19486, USA
    Proc Natl Acad Sci U S A 101:14560-6. 2004
  3. ncbi request reprint Overview: cause and prevention in biowarfare and bioterrorism
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 20:3055-67. 2002
  4. ncbi request reprint Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 21:4626-49. 2003
  5. ncbi request reprint Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 20:3068-87. 2002
  6. ncbi request reprint Personal reflections on twentieth century vaccinology
    Maurice R Hilleman
    Merck Institute for Vaccinology, West Point, PA 19118, USA
    Southeast Asian J Trop Med Public Health 34:244-8. 2003
  7. ncbi request reprint Overview: past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B
    Maurice R Hilleman
    Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    J Gastroenterol Hepatol 17:S449-51. 2002
  8. pmc Therapeutic vaccines: realities of today and hopes for tomorrow
    Michael Sela
    Weizmann Institute of Science, Rehovot 76100, Israel
    Proc Natl Acad Sci U S A 101:14559. 2004
  9. ncbi request reprint Obituary: Maurice R. Hilleman (1919-2005)
    Reinhard Kurth
    Reinhard Kurth is at the Robert Koch Institut, Nordufer 20, 13353 Berlin
    Nature 434:1083. 2005

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Overview of the needs and realities for developing new and improved vaccines in the 21st century
    Maurice R Hilleman
    Merck Institute for Vaccinology, Merck and Co, Inc, West Point, PA 19486, USA
    Intervirology 45:199-211. 2002
    ..Reductionism imposes vastly increased complexity and difficulty on vaccine development and might not be capable of achievement. The challenge in the 21st century will involve new and uncertain pathways toward worthwhile accomplishments...
  2. pmc Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections
    Maurice R Hilleman
    Merck Institute for Vaccinology, West Point, PA 19486, USA
    Proc Natl Acad Sci U S A 101:14560-6. 2004
    ..In the meantime, antiviral chemotherapy, chemotherapy/prophylactic vaccination, and short interfering RNA silencing are worthy of intense investigation...
  3. ncbi request reprint Overview: cause and prevention in biowarfare and bioterrorism
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 20:3055-67. 2002
    ....
  4. ncbi request reprint Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 21:4626-49. 2003
    ..The many facets of current hepatitis B virology, pathogenesis, immunoprophylaxis, immunotherapeusis, chemotherapy, and tumor pathogenesis and therapy are discussed here, in depth, but in keeping with needed brevity...
  5. ncbi request reprint Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control
    Maurice R Hilleman
    Merck Institute for Vaccinology, 770 Sumneytown Pike, West Point, PA 19486, USA
    Vaccine 20:3068-87. 2002
    ..This hypothesis, though remote, provides a different way to view and to probe the enigma of pandemic influenza...
  6. ncbi request reprint Personal reflections on twentieth century vaccinology
    Maurice R Hilleman
    Merck Institute for Vaccinology, West Point, PA 19118, USA
    Southeast Asian J Trop Med Public Health 34:244-8. 2003
    ..The author's career in vaccinology, which began in 1944, was recognized in the 2002 Prince Mahidol Award given in Bangkok, Thailand. This review presents the substance of the Award lecture delivered on January 29, 2003...
  7. ncbi request reprint Overview: past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B
    Maurice R Hilleman
    Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    J Gastroenterol Hepatol 17:S449-51. 2002
  8. pmc Therapeutic vaccines: realities of today and hopes for tomorrow
    Michael Sela
    Weizmann Institute of Science, Rehovot 76100, Israel
    Proc Natl Acad Sci U S A 101:14559. 2004
  9. ncbi request reprint Obituary: Maurice R. Hilleman (1919-2005)
    Reinhard Kurth
    Reinhard Kurth is at the Robert Koch Institut, Nordufer 20, 13353 Berlin
    Nature 434:1083. 2005